GlassScriptPhysician profile
Melissa D Young
NPI 1407161342
$1,851.92
in general payments reported to CMS, 2019-2025
22 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $706 · 2022: $613 · 2023: $246 · 2024: $154 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $255.70 | 2021-2023 | Lifevest |
| Lantheus Medical Imaging, INC. | $234.72 | 2021-2025 | Definity |
| Medtronic, INC. | $223.87 | 2021-2025 | Resolute Onyx |
| Amgen INC. | $213.91 | 2021-2022 | |
| Abbott Laboratories | $181.74 | 2021-2024 | Diamondback Peripheral |
| Astrazeneca Pharmaceuticals LP | $156.04 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $109.38 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.74 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $73.50 | 2021-2022 | |
| Novo Nordisk INC | $54.78 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $48.96 | 2021-2022 | |
| Boston Scientific Corporation | $40.04 | 2021-2024 | Watchman Flx |
| W. L. Gore & Associates, INC. | $23.10 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Irhythm Technologies, INC. | $23.01 | 2024 | Zio Monitor, Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.95 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $18.36 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $17.95 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.57 | 2022 | |
| Atricure, INC. | $15.85 | 2021 | |
| Chiesi USA, INC. | $15.59 | 2021 | |
| Terumo Medical Corporation | $14.03 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.